Molecular mechanisms of drug resistance in ovarian cancer

被引:192
作者
Norouzi-Barough, Leyla [1 ]
Sarookhani, Mohammad Reza [2 ]
Sharifi, Mohammadreza [3 ]
Moghbelinejad, Sahar [4 ]
Jangjoo, Saranaz [5 ]
Salehi, Rasoul [3 ]
机构
[1] Qazvin Univ Med Sci, Sch Med, Dept Mol Med, Qazvin, Iran
[2] Qazvin Univ Med Sci, Cellular & Mol Res Ctr, Qazvin, Iran
[3] Isfahan Univ Med Sci, Sch Med, Dept Genet & Mol Biol, Esfahan 81744176, Iran
[4] Qazvin Univ Med Sci, Sch Med, Dept Biochem & Genet, Qazvin, Iran
[5] Shiraz Univ Med Sci, Sch Med, Shiraz, Iran
关键词
chemotherapeutic agents; drug resistance; molecular mechanisms; ovarian cancer; LONG NONCODING RNA; GLUTATHIONE-S-TRANSFERASE; EPITHELIAL-MESENCHYMAL-TRANSITION; OXYGEN SPECIES ROS; CISPLATIN RESISTANCE; CHEMOTHERAPY RESISTANCE; MULTIDRUG-RESISTANCE; ABC TRANSPORTERS; OXIDATIVE STRESS; MDR1/P-GLYCOPROTEIN EXPRESSION;
D O I
10.1002/jcp.26289
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Ovarian cancer is the most lethal malignancy among the gynecological cancers, with a 5-year survival rate, mainly due to being diagnosed at advanced stages, recurrence and resistance to the current chemotherapeutic agents. Drug resistance is a complex phenomenon and the number of known involved genes and cross-talks between signaling pathways in this process is growing rapidly. Thus, discovering and understanding the underlying molecular mechanisms involved in chemo-resistance are crucial for management of treatment and identifying novel and effective drug targets as well as drug discovery to improve therapeutic outcomes. In this review, the major and recently identified molecular mechanisms of drug resistance in ovarian cancer from relevant literature have been investigated. In the final section of the paper, new approaches for studying detailed mechanisms of chemo-resistance have been briefly discussed.
引用
收藏
页码:4546 / 4562
页数:17
相关论文
共 201 条
[1]   Overcoming cisplatin resistance of ovarian cancer cells by targeting HIF-1-regulated cancer metabolism [J].
Ai, Zhihong ;
Lu, Yang ;
Qiu, Songbo ;
Fan, Zhen .
CANCER LETTERS, 2016, 373 (01) :36-44
[2]  
Akhdar H, 2012, TOPICS ON DRUG METABOLISM, P137
[3]   Molecular determinants of ovarian cancer chemoresistance: new insights into an old conundrum [J].
Ali, Ahmed Y. ;
Farrand, Lee ;
Kim, Ji Young ;
Byun, Sanguine ;
Suh, Jeong-Yong ;
Lee, Hyong Joo ;
Tsang, Benjamin K. .
NUTRITION AND PHYSICAL ACTIVITY IN AGING, OBESITY, AND CANCER, 2012, 1271 :58-67
[4]   Transcriptional Suppression, DNA Methylation, and Histone Deacetylation of the Regulator of G-Protein Signaling 10 (RGS10) Gene in Ovarian Cancer Cells [J].
Ali, Mourad W. ;
Cacan, Ercan ;
Liu, Yuying ;
Pierce, Jennifer Young ;
Creasman, William T. ;
Murph, Mandi M. ;
Govindarajan, Rajgopal ;
Eblen, Scott T. ;
Greer, Susanna F. ;
Hooks, Shelley B. .
PLOS ONE, 2013, 8 (03)
[5]   Studying platinum sensitivity and resistance in high-grade serous ovarian cancer: Different models for different questions [J].
Alkema, Nicolette G. ;
Wisman, G. Bea A. ;
van der Zee, Ate G. J. ;
van Vugt, Marcel A. T. M. ;
de Jong, Steven .
DRUG RESISTANCE UPDATES, 2016, 24 :55-69
[6]   Principles and Current Strategies for Targeting Autophagy for Cancer Treatment [J].
Amaravadi, Ravi K. ;
Lippincott-Schwartz, Jennifer ;
Yin, Xiao-Ming ;
Weiss, William A. ;
Takebe, Naoko ;
Timmer, William ;
DiPaola, Robert S. ;
Lotze, Michael T. ;
White, Eileen .
CLINICAL CANCER RESEARCH, 2011, 17 (04) :654-666
[7]  
[Anonymous], CHIN J CANC
[8]  
[Anonymous], INNOV PHARM PHARMACO
[9]   SENP1 desensitizes hypoxic ovarian cancer cells to cisplatin by up-regulating HIF-1α [J].
Ao, Qilin ;
Su, Wenjing ;
Guo, Shuang ;
Cai, Lei ;
Huang, Lei .
SCIENTIFIC REPORTS, 2015, 5
[10]   Hooked on fat: the role of lipid synthesis in cancer metabolism and tumour development [J].
Baenke, Franziska ;
Peck, Barrie ;
Miess, Heike ;
Schulze, Almut .
DISEASE MODELS & MECHANISMS, 2013, 6 (06) :1353-1363